-
Health Care Maintenance of Saudi Elderly Women in Outpatient Clinics
Muneerah albugami,
Yasmin Al Twaijri,
Hussam Janaid,
Abdulwahab Heggi,
Abdelazeim Elamin,
Rania Abdelreheem,
Siddiquee Mohammed,
Walae Alahmadi,
Noura Alturaif
Issue:
Volume 3, Issue 5, September 2015
Pages:
197-203
Received:
24 June 2015
Accepted:
4 August 2015
Published:
13 August 2015
Abstract: Lifestyle modifications, screenings, early identification, and appropriate intervention may prevent many chronic conditions that cause morbidity and mortality in elderly women. The objective of our study is to describe the current clinical practice of preventive health services (screening, counselling and immunization) among elderly women. This is a retrospective chart review study from January 2009 to December 2011
Abstract: Lifestyle modifications, screenings, early identification, and appropriate intervention may prevent many chronic conditions that cause morbidity and mortality in elderly women. The objective of our study is to describe the current clinical practice of preventive health services (screening, counselling and immunization) among elderly women. This is ...
Show More
-
Aminaftone in the Treatment of Raynaud’s Phenomenon in Systemic Sclerosis: New Perspectives
Simone Parisi,
Marco Scarati,
Marta Priora,
Clara Lisa Peroni,
Angela Laganà,
Enrico Fusaro
Issue:
Volume 3, Issue 5, September 2015
Pages:
204-209
Received:
3 August 2015
Accepted:
10 August 2015
Published:
19 August 2015
Abstract: Objective: The aim of this study was to assess the efficacy (in terms of improved VAS Pain, Raynaud's Phenomenon attacks frequency and Raynaud’s Condition Score) of the Aminaftone in patients with Raynaud’s Phenomenon (RP) secondary to Systemic Sclerosis (SSc). Methods: Open label controlled study. We evaluated the efficacy of Aminaftone in the treatment of secondary RP in 108 patients with SSc consecutively recruited and divided in two groups. Group A: 51 Patients in treatment with Calcium Channel Blockers, prostanoids (iloprost 2ng [min/kg every 4 weeks), Endothelin Receptor Antagonist and Phosphodiesterase-5 inhibitors (Standard of Care). Group B: 57 Patients in treatment with Calcium Channel Blockers, Prostanoids, Endothelin Receptor Antagonist and Phosphodiesterase-5 inhibitors and Aminaftone (Standard of care + Aminaftone). Results: The number of RP attacks in group treated with Aminaftone (Group B) was lower than the group treated with standard therapy (Group A) from baseline to Week 48, obtaining statistically significance (Δ A -1.50 Δ B -2.10 p=0.02 95%CI). The RCS was statistically significantly different (Δ A -1.60 Δ B -2.50 p=0,04 95% CI), as was the pain VAS(Δ A -20.80 Δ B -30.60 p=0.04 95%CI) at week 48. Conclusion: The use of Aminaftone was well tolerated and improved RP as measured by RCS and pain when added to standard of care. A well-designed randomized controlled trial is needed to determine if these preliminary findings are supported
Abstract: Objective: The aim of this study was to assess the efficacy (in terms of improved VAS Pain, Raynaud's Phenomenon attacks frequency and Raynaud’s Condition Score) of the Aminaftone in patients with Raynaud’s Phenomenon (RP) secondary to Systemic Sclerosis (SSc). Methods: Open label controlled study. We evaluated the efficacy of Aminaftone in the tre...
Show More
-
Erythema Nodosum During Adalimumab Therapy: An Idiopathic Transient Paradoxical Effect
Ilker Ilhanli,
Yunus Durmaz,
Necip Guder,
Kıvanc Cengiz
Issue:
Volume 3, Issue 5, September 2015
Pages:
210-212
Received:
16 August 2015
Accepted:
20 August 2015
Published:
29 August 2015
Abstract: Contrary to their undoubted efficacy on rheumatologic diseases, potential for developing skin lesions with Tumor necrosis alpha blockers (Anti-TNF alpha) is an important question in our minds. Although we know, most of the studies and case reports in the literature show that adalimumab is an effective treatment agent on erythema nodosum, we should keep in mind this lesion as a rare paradoxical side-effect. Here we present a case of idiopathic transient erythema nodosum during adalimumab therapy.
Abstract: Contrary to their undoubted efficacy on rheumatologic diseases, potential for developing skin lesions with Tumor necrosis alpha blockers (Anti-TNF alpha) is an important question in our minds. Although we know, most of the studies and case reports in the literature show that adalimumab is an effective treatment agent on erythema nodosum, we should ...
Show More
-
Underweight May Be a Risk Factor for Lower Bone Density in Chronic Hepatitis C Infected Male Patients
Amin R. Soliman,
Hatem Darwish,
Ahmed Hamdy,
Mahmoud A. Soliman
Issue:
Volume 3, Issue 5, September 2015
Pages:
213-216
Received:
22 August 2015
Accepted:
29 August 2015
Published:
9 September 2015
Abstract: Background/Aim of the study: Osteoporosis and osteopenia are well known complications in patients with chronic liver disease, we aimed to investigate Egyptian male patients with chronic hepatitis C infection as regard the bone mineral density and risk factors for osteoporosis in this subpopulation and correlating it to BMI (body mass index). Patients and methods: One Hundred ninety-three Egyptian male patients with hepatitis C virus CLD has been enrolled and consented: 116 under weight and 77 normal weight, Chronic HCV infection was confirmed by positive anti-HCV antibodies and HCV RNA PCR. Cirrhosis was diagnosed based on sonographic and laboratory criteria. Noninvasive methods were used: the FibroScan test was used for assessment of liver fibrosis. Blood was drawn for routine tests included total serum calcium, phosphate, creatinine and total alkaline phosphatase using standard methods. 25-hydroxy vitamin D (25OHD) were done. Bone mineral density: BMD of the lumbar spine, femoral neck: using dual energy x-ray absorptiometry (DEXA)Scan were analyzed by the same technician. Results were correlated to Body mass index and Serum vitamin D level. Results: Demographic Data and Clinical Characteristics of Under and Normal Weight Chronic Hepatitis C Men were recorded, the results showed statistically significant correlations between under and normal weight HCV patients regarding BMI and BMD (in right hip and femoral neck, p values were 0.002 and 0.004, respectively). Subnormal 25 hydroxy vitamin D levels were present in 64% of the underweight patients and 51% of the normal weight patients with no significant differences between both groups. Conclusion: the body weight and BMI might be more detrimental for low BMD in male patients with CLD secondary to HCV infection rather than vitamin D status.
Abstract: Background/Aim of the study: Osteoporosis and osteopenia are well known complications in patients with chronic liver disease, we aimed to investigate Egyptian male patients with chronic hepatitis C infection as regard the bone mineral density and risk factors for osteoporosis in this subpopulation and correlating it to BMI (body mass index). Patien...
Show More
